Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 26, 2026
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $3.1 thousand as of October 14, 2026. It is the 52,152nd most valuable company in the world and the 8,180th biggest in the United States. Its market cap has decreased by 98.67% in one year.
Market Cap
3.10K
Enterprise Value
n/a
Revenue
4.04M
Global Rank
Country Rank
#8,180 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 3.10K, a decrease of -99.98%. That is a compound annual growth rate of -25.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 3.10K | - |
| Dec 9, 2025 | 3.10K | 100.00% |
| Dec 28, 2022 | 1.55K | -98.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Evelo Biosciences | 3.80K |
| Synovics Pharmaceuticals | 3.65K |
| Anthera Pharmaceuticals | 3.53K |
| Rebus Holdings | 3.21K |
| Comera Life Sciences Holdings | 3.07K |